Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36 pseudogene 3 (RPL36P3) is a processed pseudogene in the human genome. Pseudogenes are DNA sequences similar to known genes but are nonfunctional due to mutations or lack of necessary regulatory elements. RPL36P3 is related in sequence to the functional RPL36 gene, which encodes a component of the ribosomal 60S subunit involved in protein synthesis. However, RPL36P3 itself does not produce a functional protein and does not encode a receptor, enzyme, transporter, or transcription factor. There is no evidence that RPL36P3 has any biological function, disease association, or therapeutic targeting relevance[7][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36 pseudogene 3 (RPL36P3).